Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

10.79 -0.30 (-2.71%)
Streaming Delayed Price Updated: 10:37 AM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Intellia Therapeutics, Inc. - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
21 22 Next >
News headline image
Here's the Secret Behind Cathie Wood's Latest Moneymaking Strategy ↗
Success could be in the DNA of the Ark Invest founder. 
Via The Motley Fool
News headline image
How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities ↗
The field of biotechnology has become a driving force behind groundbreaking medical advancements, offering investors the opportunity to benefit from these innovations. Here are 10 healthcare innovators... 
Via Talk Markets
News headline image
3 Cathie Wood Investments That Could Deliver Superior Returns ↗
These three stocks fit Wood's profile for big-time growth. 
Via The Motley Fool
News headline image
2 Short-Squeeze Candidates That Could Go Parabolic ↗
Editas Medicine and Bluebird Bio have been favorite targets for short-sellers lately. 
Via The Motley Fool
News headline image
2 Growth Stocks Cathie Wood Is Buying Hand Over Fist ↗
The fund manager most famous for innovation-focused investing thinks these two stocks have what it takes to produce big gains. 
Via The Motley Fool
News headline image
What 10 Analyst Ratings Have To Say About Intellia Therapeutics ↗
 
Via Benzinga
News headline image
Where Intellia Therapeutics Stands With Analysts ↗
 
Via Benzinga
News headline image
Why Is Intellia (NTLA) Stock Up 5% Today? ↗
NTLA stock is trending on social media and is up over 5%. The drugmaker reported new, positive results from its gene-edited treatment. 
Via InvestorPlace
News headline image
Can This Gene-Editing Stock Deliver 10X Returns? ↗
Buying shares of Intellia Therapeutics might be a smart move. 
Via The Motley Fool
News headline image
Hereditary Angioedema Update Solidifies Intellia's Cell Therapy's Competitive Efficacy Profile: Analyst ↗
Sunday, Intellia Therapeutics Inc (NASDAQ: NTLA) announced updated interim results from the Phase 1 portion of the ongoing  
Via Benzinga
News headline image
Why Are Cruise Stocks CCL, RCL, NCLH Up Today? ↗
Cruise stocks are on the rise Monday as investors react to a positive note to clients from JPMorgan analysts and we've got the details! 
Via InvestorPlace
News headline image
BIIB Stock Alert: Biogen Resumes Trading With New FDA Backing ↗
Biogen (BIIB) stock is a hot topic among traders Monday as the company's share resumed trading following a halt that was in effect on Friday. 
Via InvestorPlace
News headline image
Intellia Therapeutics Surges As CRISPR Gene-Editing Drug Potentially Cures Swelling Disease ↗
The company is testing a treatment for hereditary angioedemia, a potentially fatal swelling disorder. 
Via Investor's Business Daily
News headline image
Why Intellia Therapeutics Stock Is Rising Monday ↗
Intellia Therapeutics Inc (NASDAQ: NTLA) shares are trading higher Monday after the clinical-stage genome editing company announced data for its treatment for people living with hereditary angioedema... 
Via Benzinga
News headline image
Chinook Therapeutics, Oracle And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Chinook Therapeutics, Inc. (NASDAQ: KDNY) shares jumped 66.8% to $40.01 in... 
Via Benzinga
News headline image
12 Analysts Have This to Say About Intellia Therapeutics ↗
 
Via Benzinga
News headline image
Intellia Therapeutics: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Wall Street Says These 2 Stocks May Double. Should You Buy Them? ↗
Both of these stocks have declined over the past year. 
Via The Motley Fool
News headline image
Cathie Wood Is Loading Up on These 3 Stocks Down 70% or More. Should You? ↗
The Ark Invest CEO is betting on rebounds for these beaten-down stocks. 
Via The Motley Fool
News headline image
Why Intellia Therapeutics Shares Are Surging Today ↗
Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares are up Thursday as its Q1 results surpassed estimates. The company looks forward to sharing new interim data from NTLA-2001 and NTLA-2002... 
Via Benzinga
News headline image
Intellia Therapeutics's Earnings Outlook ↗
 
Via Benzinga
News headline image
The 3 Most Promising Gene Editing Stocks to Buy in 2023 ↗
Intellia, Beam, and Editas are using gene editing to cure incurable diseases. These are three gene editing stocks you'll want to invest in. 
Via InvestorPlace
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
The popular growth investor has stumbled after a hot start to 2023, but Wood keeps adding to some of her favorite positions. 
Via The Motley Fool
News headline image
3 Biotech Stocks to Watch After Johnson & Johnson’s Earnings Beat ↗
Discover the latest picks in the biotech industry with our article on 3 biotech stocks to watch after Johnson & Johnson’s earnings beat. 
Via InvestorPlace
News headline image
3 High-Growth Biotech Stocks Poised for Success in 2023 ↗
If you look for growth opportunities wherever you can find them, there are some high-growth biotech stocks that could present an opportunity 
Via InvestorPlace
News headline image
2 Monster Growth Stocks That Can Double in Value, According to Wall Street ↗
These stocks have some promising growth opportunities, but they also come with a fair amount of risk. 
Via The Motley Fool
News headline image
Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today? ↗
While CRSPR stock captured the spotlight for potentially encouraging drug data, the news lifted other gene-editing stocks. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023 ↗
 
Via Benzinga
News headline image
Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global ↗
 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.